Navigation Links
Anti-cancer drug damages brain vessels
Date:2/11/2008

The cancer drug Avastin (bevacizumab) is used to treat advanced bowel cancer in combination with chemotherapy. This drug targets a protein called VEGF (vascular endothelial growth factor) that stimulates blood vessel growth. Avastin inhibits the growth of tumors by cutting off their blood supply, which deprives them of oxygen and other nutrients. In a small percentage of patients, however, Avastin can cause neurological side effects ranging from headaches and blurry vision to potentially fatal seizures and brain swelling.

The new study reveals that VEGF normally protects the specialized cells that create a seal between the brain and spinal column and thus prevent fluid from leaking into the brain. When VEGF was blocked in mice, these cells died and the animals developed brain swelling. The authors suspect that Avastins side effects in humans may be caused by a similar phenomenon. Why these symptoms occur in only a few patients is not yet known.


'/>"/>

Contact: Hema Bashyam
hbashyam@rockefeller.edu
212-327-7053
Journal of Experimental Medicine
Source:Eurekalert

0

GOOD

Page: 1

Related medicine news :

1. Synthesis of natural molecule could lead to better anti-cancer drugs
2. Carbon monoxide counteracts one side-effect of an anti-cancer drug
3. Scientific evidence of the significant anti-cancer effect of milk thistle
4. Telomerase enzyme structure provides significant new target for anti-cancer therapies
5. A Chinese medicine compound has satisfactory anti-cancer effects on hepatocellular carcinoma
6. Aida Granted Additional Anti-Cancer Patent
7. Discovery of widespread tumor growth gene holds promise for effective anti-cancer treatment
8. Experimental anti-cancer drug made from corn lillies kills brain tumor stem cells
9. Novel MRI Technique Shows Secondhand Smoke Damages Lungs
10. Special MRI Shows Secondhand Smoke Damages Lungs
11. Secondhand smoke damages lungs, MRIs show
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...Trusted life science software provider allows fede... via GSA. , Reston, VA (P...g software engineering firm dedicated to the life...ervices Administration (GSA) Contract. The GSA IT ... ability to conveniently engage 5AM Solutions, sof...
(Date:8/28/2008)...nical efforts of the Maryland Medicaid contract, ...national medical,management firm, appointed Lenaye...ector. Dr. Lawyer will oversee all clinical aspect...s Hunt Valley, Maryland Harrisburg,office., "Dr. ...Maryland," said,Alice Stollenwerk Petrulis, MD, FA...
(Date:8/28/2008)... eating raw Mexican jalapeno and serrano peppers ...- U.S. health officials declared Thursday that the... the consumer advisory against eating raw jalapeno...ed. , "Based on the available information and ...r. Robert Tauxe, deputy director of the U.S. Cente...
(Date:8/28/2008)..., not injury itself, associated with increased pla...s) -- A group of researchers has described hourly ...to play a key role in Alzheimer,s disease. , I..., was directly linked to brain cell communication ...n cell communication increased, so did amyloid bet...
Breaking Medicine News(10 mins):Health News:Federal and State Agencies Have Easier Access to 5AM Solutions' Award-Winning Software Services 2Health News:Lenaye Lawyer, MD, FACOG, Named KePRO Medical Director 2Health News:Salmonella Outbreak Over, U.S. Says 2Health News:Salmonella Outbreak Over, U.S. Says 3Health News:Scientists Track Hourly Changes in Alzheimer's Protein 2
...The Indian Medical Association (IMA) has accused U...sthesis in India at cheaper prices . "It is shocki... prosthesis in India," IMA president Ajay Kumar sa...d that US companies are selling knee and hip prost...
...Japan is a step closer to having an ideal worker w...y floors as a company unveiled a next-generation h...t Mk-II, a 160-centimetre-tall (five feet, four in...d on a slippery floor scattered with sand and held...
...According to a RAND Corporation study issued today...hronically ill children when given greater access ...ir jobs. We found that having the time and finan...ly important for parents who have children with se...
...Researchers at Washington University School of Med...rferes with ligament healing. Studying mice with...ette smoking impairs the recruitment of cells to t... ligament-repair surgery. They reported their find...
Other Medicine News:Health News:Employer Leave Helps the Parents of Chronically Ill Kids 2Health News:Employer Leave Helps the Parents of Chronically Ill Kids 3Health News:Cigarette Smoking Delays Ligament Healing 2Health News:Cigarette Smoking Delays Ligament Healing 3
(Date:8/26/2008)...26 /- XTENT, Inc.,(Nasdaq: ... follow-up data,from the CUSTOM II trial was publi... journal, EuroIntervention. The lead author of the...sity Medical Center Utrecht, Utrecht,The Netherla...13 clinical,sites across Europe., The one-year CU...
(Date:8/25/2008)...ug. 25 /- Joseph F. Finn, Jr.,C.P.A..... ("Spherics") for,the benefit of creditors, annou...operty will be sold at a sealed bid auction on Oct...rmulation of Levodopa-Carbidopa that,is the curren... with global,sales estimated at approximately $250...
(Date:8/22/2008)...22 /-, - Dangerous Bacteria Infect T...es something well-tried can also be innovative: al...be very antimicrobial. This,ability is now playing...us,hospital germs. In a worldwide noted field test... Wandsbek in Hamburg, Germany, was equipped with,d...
(Date:8/21/2008)...ows clinical potential in independent study of ... COLUMBIA, Md., Aug. 21 /- A recently...linical Transplantation has expanded our,understan...mediated,immunity in adult patients at risk for or...ansplantation., Pablo Sanchez-Velasco and his col...
Breaking Medicine Technology:XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 2XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 4Spherics, Inc. Offers Extended Release Formulation for Sustained and Stable Levodopa Levels 2Copper Eliminates Resistant Hospital Germs in a Worldwide Field Test 2Copper Eliminates Resistant Hospital Germs in a Worldwide Field Test 3New Data Support Role for Monitoring of Cell-Mediated Immunity in Adult Patients Following Renal Transplantation 2New Data Support Role for Monitoring of Cell-Mediated Immunity in Adult Patients Following Renal Transplantation 3Heat Exposure a Dangerous Summer Threat 23620 1Heat Exposure a Dangerous Summer Threat 23620 2National Non Profit EyeCare America and the Maryland Society of Eye Physicians 26amp 3B Surgeons Host Finish Line Celebration for 26amp 3B 238220 23618 1National Non Profit EyeCare America and the Maryland Society of Eye Physicians 26amp 3B Surgeons Host Finish Line Celebration for 26amp 3B 238220 23618 2National Non Profit EyeCare America and the Maryland Society of Eye Physicians 26amp 3B Surgeons Host Finish Line Celebration for 26amp 3B 238220 23618 3National Non Profit EyeCare America and the Maryland Society of Eye Physicians 26amp 3B Surgeons Host Finish Line Celebration for 26amp 3B 238220 23618 4Northern Kentucky Voters Support Smokefree Workplaces 23614 1Northern Kentucky Voters Support Smokefree Workplaces 23614 2Northern Kentucky Voters Support Smokefree Workplaces 23614 3Northern Kentucky Voters Support Smokefree Workplaces 23614 4AMA Calls On U S Senate to Pass H R 6331 Today to Preserve Seniors Access to Care 23610 1
..., May 22, 2007 /PRNewswire-FirstCall/ -- Forest,La...y announced,that preliminary top-line results from...lind, placebo-controlled pivotal Phase III,study d...ffects of,milnacipran as a treatment of fibromyalg...been able to review initial top-line,results and f...
...ate Thrombosis is Minimized with Genous Stent, BAR...ficacy of,OrbusNeich,s Genous(TM) Bio-engineered R...stents, while the risk of late thrombosis,is minim...m,analysis of post-marketing data presented today ... in Barcelona, Spain. , Collected from more than 1...
Other Medicine Technology:Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce,Positive Results of Phase III Study for Milnacipran as a Treatment,for Fibromyalgia Syndrome 2Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce,Positive Results of Phase III Study for Milnacipran as a Treatment,for Fibromyalgia Syndrome 3Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce,Positive Results of Phase III Study for Milnacipran as a Treatment,for Fibromyalgia Syndrome 4Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce,Positive Results of Phase III Study for Milnacipran as a Treatment,for Fibromyalgia Syndrome 5Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce,Positive Results of Phase III Study for Milnacipran as a Treatment,for Fibromyalgia Syndrome 6Efficacy of OrbusNeich's Genous Bio-Engineered R Stent Compares,Favorably to Drug-Eluting Stents 2Efficacy of OrbusNeich's Genous Bio-Engineered R Stent Compares,Favorably to Drug-Eluting Stents 3
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
Medicine Products: